Published in Proc Natl Acad Sci U S A on August 19, 2011
3D In vitro model of a functional epidermal permeability barrier from human embryonic stem cells and induced pluripotent stem cells. Stem Cell Reports (2014) 2.42
In vitro modeling of hyperpigmentation associated to neurofibromatosis type 1 using melanocytes derived from human embryonic stem cells. Proc Natl Acad Sci U S A (2015) 1.40
Modeling neural crest induction, melanocyte specification, and disease-related pigmentation defects in hESCs and patient-specific iPSCs. Cell Rep (2013) 1.36
Selective tropism of Seneca Valley virus for variant subtype small cell lung cancer. J Natl Cancer Inst (2013) 1.02
Generation of folliculogenic human epithelial stem cells from induced pluripotent stem cells. Nat Commun (2014) 0.92
Potential for pharmacological manipulation of human embryonic stem cells. Br J Pharmacol (2013) 0.85
Narrowing the knowledge gaps for melanoma. Ups J Med Sci (2012) 0.84
Retinoid-X-receptors (α/β) in melanocytes modulate innate immune responses and differentially regulate cell survival following UV irradiation. PLoS Genet (2014) 0.83
Melanocytes derived from transgene-free human induced pluripotent stem cells. J Invest Dermatol (2013) 0.80
Human neural crest cells contribute to coat pigmentation in interspecies chimeras after in utero injection into mouse embryos. Proc Natl Acad Sci U S A (2016) 0.78
Melanin Transfer in Human 3D Skin Equivalents Generated Exclusively from Induced Pluripotent Stem Cells. PLoS One (2015) 0.77
Understanding Melanocyte Stem Cells for Disease Modeling and Regenerative Medicine Applications. Int J Mol Sci (2015) 0.76
The NF1 gene in tumor syndromes and melanoma. Lab Invest (2017) 0.75
Extracellular Matrix and Integrins in Embryonic Stem Cell Differentiation. Biochem Insights (2015) 0.75
Prospect of Human Pluripotent Stem Cell-Derived Neural Crest Stem Cells in Clinical Application. Stem Cells Int (2016) 0.75
Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42
Embryonic stem cell lines derived from human blastocysts. Science (1998) 65.53
Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science (2008) 14.26
A new syndrome combining developmental anomalies of the eyelids, eyebrows and nose root with pigmentary defects of the iris and head hair and with congenital deafness. Am J Hum Genet (1951) 12.38
Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature (2008) 12.21
c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell (2007) 8.46
Guidelines and techniques for the generation of induced pluripotent stem cells. Cell Stem Cell (2008) 7.57
Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci U S A (2008) 7.52
Isolation and directed differentiation of neural crest stem cells derived from human embryonic stem cells. Nat Biotechnol (2007) 3.48
Technical challenges in using human induced pluripotent stem cells to model disease. Cell Stem Cell (2009) 3.42
Directed differentiation of human embryonic stem cells into functional retinal pigment epithelium cells. Cell Stem Cell (2009) 3.09
Developmental study of fragile X syndrome using human embryonic stem cells derived from preimplantation genetically diagnosed embryos. Cell Stem Cell (2007) 2.87
A syndrome associating partial albinism and immunodeficiency. Am J Med (1978) 2.19
Fifteen-year quest for microphthalmia-associated transcription factor target genes. Pigment Cell Melanoma Res (2009) 2.01
Neural crest induction in Xenopus: evidence for a two-signal model. Development (1998) 1.99
The making of a melanocyte: the specification of melanoblasts from the neural crest. Pigment Cell Melanoma Res (2008) 1.96
Rescue of the albino phenotype by introduction of a functional tyrosinase gene into mice. EMBO J (1990) 1.91
Human embryonic stem-cell derivatives for full reconstruction of the pluristratified epidermis: a preclinical study. Lancet (2009) 1.91
Mutant human embryonic stem cells reveal neurite and synapse formation defects in type 1 myotonic dystrophy. Cell Stem Cell (2011) 1.71
Soluble and cell-bound forms of steel factor activity play distinct roles in melanocyte precursor dispersal and survival on the lateral neural crest migration pathway. Development (1995) 1.64
Regulation of Msx genes by a Bmp gradient is essential for neural crest specification. Development (2003) 1.54
Tissue grafts in vitiligo surgery - past, present, and future. Indian J Dermatol (2009) 1.51
The ontogeny of the neural crest in avian embryo chimaeras. Nature (1980) 1.47
Derivation of human embryonic stem cell lines from embryos obtained after IVF and after PGD for monogenic disorders. Hum Reprod (2005) 1.44
The role of Kit-ligand in melanocyte development and epidermal homeostasis. Pigment Cell Res (2003) 1.44
Posteriorization by FGF, Wnt, and retinoic acid is required for neural crest induction. Dev Biol (2002) 1.39
Transcription factors in melanocyte development: distinct roles for Pax-3 and Mitf. Mech Dev (2001) 1.39
The inductive properties of mesoderm suggest that the neural crest cells are specified by a BMP gradient. Dev Biol (1998) 1.39
The endothelin receptor-B is required for the migration of neural crest-derived melanocyte and enteric neuron precursors. Dev Biol (2003) 1.32
BMP signaling is essential for development of skeletogenic and neurogenic cranial neural crest. Development (2000) 1.30
Defining the conditions for the generation of melanocytes from human embryonic stem cells. Stem Cells (2006) 1.27
Neural crest development: the interplay between morphogenesis and cell differentiation. Curr Top Dev Biol (1998) 1.24
New potential for human embryonic stem cells. Science (1998) 1.21
An immunohistological study of cutaneous lymphocytes in vitiligo. J Pathol (1993) 1.21
BMP-4 induces a Smad-dependent apoptotic cell death of mouse embryonic stem cell-derived neural precursors. Cell Death Differ (2005) 1.20
Regulation of Slug transcription in embryonic ectoderm by beta-catenin-Lef/Tcf and BMP-Smad signaling. Dev Growth Differ (2005) 1.14
Mouse models for four types of Waardenburg syndrome. Pigment Cell Res (2003) 1.07
The avian embryo as a model to study the development of the neural crest: a long and still ongoing story. Mech Dev (2004) 1.07
Derivation of melanocytes from embryonic stem cells in culture. Dev Dyn (1999) 1.04
Mouse and hamster mutants as models for Waardenburg syndromes in humans. J Med Genet (1990) 1.02
Migratory patterns of cloned neural crest melanocytes injected into host chicken embryos. Proc Natl Acad Sci U S A (1979) 0.91
Current remedies for vitiligo. Autoimmun Rev (2010) 0.89
The neural crest: understanding stem cell function in development and disease. Neurodegener Dis (2007) 0.86
The neural crest: what can it tell us about cell migration and determination? Curr Top Dev Biol (1980) 0.83
Embryonic stem cells as a model for studying melanocyte development. Methods Mol Biol (2010) 0.77
The reconstructed epidermis with melanocytes: a new tool to study pigmentation and photoprotection. Cell Mol Biol (Noisy-le-grand) (1999) 0.77
Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: a long-term follow-up study. Lancet Neurol (2006) 2.99
Human embryonic stem cells reveal recurrent genomic instability at 20q11.21. Nat Biotechnol (2008) 2.84
Functions of adaptor protein (AP)-3 and AP-1 in tyrosinase sorting from endosomes to melanosomes. Mol Biol Cell (2005) 2.56
IGF1 promotes resistance to apoptosis in melanoma cells through an increased expression of BCL2, BCL-X(L), and survivin. J Invest Dermatol (2007) 2.31
A lumenal domain-dependent pathway for sorting to intralumenal vesicles of multivesicular endosomes involved in organelle morphogenesis. Dev Cell (2006) 2.29
Targeted activation of innate immunity for therapeutic induction of autophagy and apoptosis in melanoma cells. Cancer Cell (2009) 2.28
Striatal progenitors derived from human ES cells mature into DARPP32 neurons in vitro and in quinolinic acid-lesioned rats. Proc Natl Acad Sci U S A (2008) 2.01
AP-1 and KIF13A coordinate endosomal sorting and positioning during melanosome biogenesis. J Cell Biol (2009) 1.99
Human embryonic stem-cell derivatives for full reconstruction of the pluristratified epidermis: a preclinical study. Lancet (2009) 1.91
A directed screen for chlamydial proteins secreted by a type III mechanism identifies a translocated protein and numerous other new candidates. Mol Microbiol (2005) 1.76
Mutant human embryonic stem cells reveal neurite and synapse formation defects in type 1 myotonic dystrophy. Cell Stem Cell (2011) 1.71
TI-VAMP/VAMP7 is required for optimal phagocytosis of opsonised particles in macrophages. EMBO J (2004) 1.71
Toward the development of a global induced pluripotent stem cell library. Cell Stem Cell (2013) 1.70
Neural transplantation for the treatment of Parkinson's disease. Lancet Neurol (2003) 1.64
Dopaminergic function and dopamine transporter binding assessed with positron emission tomography in Parkinson disease. Arch Neurol (2002) 1.54
Different microtubule motors move early and late endocytic compartments. Traffic (2008) 1.50
The role of human leukocyte antigen matching in the development of multiethnic "haplobank" of induced pluripotent stem cell lines. Stem Cells (2012) 1.46
N-terminal domains elicit formation of functional Pmel17 amyloid fibrils. J Biol Chem (2009) 1.28
Glycogen synthase kinase 3beta is activated by cAMP and plays an active role in the regulation of melanogenesis. J Biol Chem (2002) 1.27
Contribution of gap junctional communication between tumor cells and astroglia to the invasion of the brain parenchyma by human glioblastomas. BMC Cell Biol (2005) 1.21
Molecular mechanisms underlying effects of epidermal growth factor receptor inhibition on invasion, proliferation, and angiogenesis in experimental glioma. Clin Cancer Res (2009) 1.18
Microphthalmia associated transcription factor is a target of the phosphatidylinositol-3-kinase pathway. J Invest Dermatol (2003) 1.17
Unique preservation of neural cells in Hutchinson- Gilford progeria syndrome is due to the expression of the neural-specific miR-9 microRNA. Cell Rep (2012) 1.16
Functional recovery in a primate model of Parkinson's disease following motor cortex stimulation. Neuron (2004) 1.15
Water diffusion compartmentation at high b values in ischemic human brain. AJNR Am J Neuroradiol (2004) 1.14
Assessing the localization of centrosomal proteins by PALM/STORM nanoscopy. Cytoskeleton (Hoboken) (2011) 1.11
miR-125 potentiates early neural specification of human embryonic stem cells. Development (2012) 1.09
Striatal neural grafting improves cortical metabolism in Huntington's disease patients. Brain (2003) 1.09
Construction of skin equivalents for gene therapy of recessive dystrophic epidermolysis bullosa. Hum Gene Ther (2004) 1.08
Invasion of human glioma biopsy specimens in cultures of rodent brain slices: a quantitative analysis. J Neurosurg (2002) 1.06
Bloom's syndrome and PICH helicases cooperate with topoisomerase IIα in centromere disjunction before anaphase. PLoS One (2012) 1.06
Plastin 1 binds to keratin and is required for terminal web assembly in the intestinal epithelium. Mol Biol Cell (2009) 1.06
Ang2/fat-free is a conserved subunit of the Golgi-associated retrograde protein complex. Mol Biol Cell (2010) 1.06
Protein transfer into human cells by VSV-G-induced nanovesicles. Mol Ther (2011) 1.04
BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells. Proc Natl Acad Sci U S A (2013) 1.04
Chloride transport in nasal ciliated cells of cystic fibrosis heterozygotes. Am J Respir Crit Care Med (2005) 1.03
Human pluripotent stem cells in drug discovery and predictive toxicology. Biochem Soc Trans (2010) 1.01
A new role for the architecture of microvillar actin bundles in apical retention of membrane proteins. Mol Biol Cell (2011) 1.00
An in vitro beating heart model for long-term assessment of experimental therapeutics. Cardiovasc Res (2008) 0.99
Alloimmunisation to donor antigens and immune rejection following foetal neural grafts to the brain in patients with Huntington's disease. PLoS One (2007) 0.99
Predictive value of early 18F-FDG PET/CT studies for treatment response evaluation to ipilimumab in metastatic melanoma: preliminary results of an ongoing study. Eur J Nucl Med Mol Imaging (2014) 0.98
Primary ciliogenesis requires the distal appendage component Cep123. Biol Open (2013) 0.97
Human pluripotent stem cells for disease modelling and drug screening. Bioessays (2011) 0.97
miR-203 modulates epithelial differentiation of human embryonic stem cells towards epidermal stratification. Dev Biol (2011) 0.95
Recurrent genomic instability of chromosome 1q in neural derivatives of human embryonic stem cells. J Clin Invest (2012) 0.95
Sensing radiosensitivity of human epidermal stem cells. Radiother Oncol (2007) 0.94
High-efficiency derivation of human embryonic stem cell lines following pre-implantation genetic diagnosis. In Vitro Cell Dev Biol Anim (2010) 0.94
A novel Src kinase inhibitor reduces tumour formation in a skin carcinogenesis model. Carcinogenesis (2008) 0.94
The antalgic efficacy of chronic motor cortex stimulation is related to sensory changes in the painful zone. Brain (2002) 0.93
Evolutionary forces shape the human RFPL1,2,3 genes toward a role in neocortex development. Am J Hum Genet (2008) 0.93
Transgenic expression of CTLA4-Ig by fetal pig neurons for xenotransplantation. Transgenic Res (2005) 0.93
Transplantation in Parkinson's disease: PET changes correlate with the amount of grafted tissue. Mov Disord (2003) 0.93
Improvement of culture conditions of human embryoid bodies using a controlled perfused and dialyzed bioreactor system. Tissue Eng Part C Methods (2008) 0.92
Production of reactive oxygen species is turned on and rapidly shut down in epithelial cells infected with Chlamydia trachomatis. Infect Immun (2009) 0.91
Induced pluripotent stem cells reveal functional differences between drugs currently investigated in patients with hutchinson-gilford progeria syndrome. Stem Cells Transl Med (2014) 0.91
High throughput screening for inhibitors of REST in neural derivatives of human embryonic stem cells reveals a chemical compound that promotes expression of neuronal genes. Stem Cells (2013) 0.90
Human embryonic stem cells and genomic instability. Regen Med (2009) 0.90
Early transcriptional changes linked to naturally occurring Huntington's disease mutations in neural derivatives of human embryonic stem cells. Hum Mol Genet (2012) 0.90
Antiangiogenic therapy against experimental glioblastoma using genetically engineered cells producing interferon-alpha, angiostatin, or endostatin. Hum Gene Ther (2003) 0.90
Corticostriatopallidal neuroprotection by adenovirus-mediated ciliary neurotrophic factor gene transfer in a rat model of progressive striatal degeneration. J Neurosci (2002) 0.89
Organotypic heart slices for cell transplantation and physiological studies. Organogenesis (2009) 0.88
The wobbler mouse: a neurodegeneration jigsaw puzzle. Mol Neurobiol (2003) 0.88
Embryonic stem cells neural differentiation qualifies the role of Wnt/β-Catenin signals in human telencephalic specification and regionalization. Stem Cells (2013) 0.88
Effects of the proteasome inhibitor ritonavir on glioma growth in vitro and in vivo. Mol Cancer Ther (2004) 0.88
The role of the striatum in rule application: the model of Huntington's disease at early stage. Brain (2005) 0.87
Severe deficiency of the fatty acid amide hydrolase (FAAH) activity segregates with the Huntington's disease mutation in peripheral lymphocytes. Neurobiol Dis (2007) 0.87
Kinesin KIFC1 actively transports bare double-stranded DNA. Nucleic Acids Res (2013) 0.87
The implementation of novel collaborative structures for the identification and resolution of barriers to pluripotent stem cell translation. Stem Cells Dev (2013) 0.86
Fibroblast growth factor type 2 signaling is critical for DNA repair in human keratinocyte stem cells. Stem Cells (2010) 0.86
How can human pluripotent stem cells help decipher and cure Huntington's disease? Cell Stem Cell (2012) 0.84
Embryonic stem cells: meeting the needs for cell therapy. Adv Drug Deliv Rev (2005) 0.83
Myosin VI regulates actin dynamics and melanosome biogenesis. Traffic (2012) 0.83
Molecular and functional MDR1-Pgp and MRPs expression in human glioblastoma multiforme cell lines. Int J Cancer (2002) 0.82
The SEURAT-1 approach towards animal free human safety assessment. ALTEX (2014) 0.81
Human pluripotent stem cell therapy for Huntington's disease: technical, immunological, and safety challenges human pluripotent stem cell therapy for Huntington's disease: technical, immunological, and safety challenges. Neurotherapeutics (2011) 0.81
CD98hc (SLC3A2) is a key regulator of keratinocyte adhesion. J Dermatol Sci (2011) 0.81
mTOR-dependent proliferation defect in human ES-derived neural stem cells affected by myotonic dystrophy type 1. J Cell Sci (2013) 0.81
Sas-4 proteins are required during basal body duplication in Paramecium. Mol Biol Cell (2011) 0.81
Antagonistic effect of the inflammasome on thymic stromal lymphopoietin expression in the skin. J Allergy Clin Immunol (2013) 0.80
Development of a global network of induced pluripotent stem cell haplobanks. Regen Med (2015) 0.79
Concise review: Epidermal grafting: the case for pluripotent stem cells. Stem Cells (2011) 0.79
In vitro pathological modelling using patient-specific induced pluripotent stem cells: the case of progeria. Biochem Soc Trans (2011) 0.79
[Therapeutic effect of human mesenchymal stem cells in skin after radiation damage]. J Soc Biol (2005) 0.79
Electrophysiological deterioration over time in patients with Huntington's disease. Mov Disord (2006) 0.79
Pluripotent stem cells as a model to study non-coding RNAs function in human neurogenesis. Front Cell Neurosci (2013) 0.79
A defective Krab-domain zinc-finger transcription factor contributes to altered myogenesis in myotonic dystrophy type 1. Hum Mol Genet (2013) 0.78
[Human pluripotent stem cells: opening key for pathological modeling]. Med Sci (Paris) (2011) 0.78
Human pluripotent stem cells for genetic disease modeling and drug screening. Regen Med (2011) 0.78
Fetal neural grafts for Huntington's disease: a prospective view. Mov Disord (2002) 0.78